Relationship between RANO-PRO Working Group standardised priority constructs and disease progression among malignant glioma patients: A retrospective cohort study.

Autor: Vera E; Neuro-Oncology Branch, Center for Cancer Research, US National Cancer Institute, 9030 Old Georgetown Road, Bldg 82, Bethesda, MD 20814, United States of America., Christ A; Neuro-Oncology Branch, Center for Cancer Research, US National Cancer Institute, 9030 Old Georgetown Road, Bldg 82, Bethesda, MD 20814, United States of America., Grajkowska E; Neuro-Oncology Branch, Center for Cancer Research, US National Cancer Institute, 9030 Old Georgetown Road, Bldg 82, Bethesda, MD 20814, United States of America., Briceno N; Neuro-Oncology Branch, Center for Cancer Research, US National Cancer Institute, 9030 Old Georgetown Road, Bldg 82, Bethesda, MD 20814, United States of America., Choi A; Neuro-Oncology Branch, Center for Cancer Research, US National Cancer Institute, 9030 Old Georgetown Road, Bldg 82, Bethesda, MD 20814, United States of America., Crandon SK; Neuro-Oncology Branch, Center for Cancer Research, US National Cancer Institute, 9030 Old Georgetown Road, Bldg 82, Bethesda, MD 20814, United States of America., Wall K; Neuro-Oncology Branch, Center for Cancer Research, US National Cancer Institute, 9030 Old Georgetown Road, Bldg 82, Bethesda, MD 20814, United States of America., Lindsley M; Neuro-Oncology Branch, Center for Cancer Research, US National Cancer Institute, 9030 Old Georgetown Road, Bldg 82, Bethesda, MD 20814, United States of America., Leeper HE; Neuro-Oncology Branch, Center for Cancer Research, US National Cancer Institute, 9030 Old Georgetown Road, Bldg 82, Bethesda, MD 20814, United States of America., Levine J; Center for Cancer Research, US National Cancer Institute, Room 2W322, Rockville, MD 20850, United States of America., Reyes J; Neuro-Oncology Branch, Center for Cancer Research, US National Cancer Institute, 9030 Old Georgetown Road, Bldg 82, Bethesda, MD 20814, United States of America., Acquaye AA; Neuro-Oncology Branch, Center for Cancer Research, US National Cancer Institute, 9030 Old Georgetown Road, Bldg 82, Bethesda, MD 20814, United States of America., King AL; Neuro-Oncology Branch, Center for Cancer Research, US National Cancer Institute, 9030 Old Georgetown Road, Bldg 82, Bethesda, MD 20814, United States of America., Jammula V; Neuro-Oncology Branch, Center for Cancer Research, US National Cancer Institute, 9030 Old Georgetown Road, Bldg 82, Bethesda, MD 20814, United States of America., Roche K; Neuro-Oncology Branch, Center for Cancer Research, US National Cancer Institute, 9030 Old Georgetown Road, Bldg 82, Bethesda, MD 20814, United States of America., Rogers JL; Neuro-Oncology Branch, Center for Cancer Research, US National Cancer Institute, 9030 Old Georgetown Road, Bldg 82, Bethesda, MD 20814, United States of America., Timmer M; Neuro-Oncology Branch, Center for Cancer Research, US National Cancer Institute, 9030 Old Georgetown Road, Bldg 82, Bethesda, MD 20814, United States of America., Boris L; Neuro-Oncology Branch, Center for Cancer Research, US National Cancer Institute, 9030 Old Georgetown Road, Bldg 82, Bethesda, MD 20814, United States of America., Lollo N; Neuro-Oncology Branch, Center for Cancer Research, US National Cancer Institute, 9030 Old Georgetown Road, Bldg 82, Bethesda, MD 20814, United States of America., Panzer M; Neuro-Oncology Branch, Center for Cancer Research, US National Cancer Institute, 9030 Old Georgetown Road, Bldg 82, Bethesda, MD 20814, United States of America., Polskin L; Neuro-Oncology Branch, Center for Cancer Research, US National Cancer Institute, 9030 Old Georgetown Road, Bldg 82, Bethesda, MD 20814, United States of America., Pillai T; Neuro-Oncology Branch, Center for Cancer Research, US National Cancer Institute, 9030 Old Georgetown Road, Bldg 82, Bethesda, MD 20814, United States of America., Burton E; Neuro-Oncology Branch, Center for Cancer Research, US National Cancer Institute, 9030 Old Georgetown Road, Bldg 82, Bethesda, MD 20814, United States of America., Penas-Prado M; Neuro-Oncology Branch, Center for Cancer Research, US National Cancer Institute, 9030 Old Georgetown Road, Bldg 82, Bethesda, MD 20814, United States of America., Theeler B; Department of Neurology, School of Medicine, Uniformed Services University of the Health Sciences, 4301 Jones Bridge Rd, Bethesda, MD 20814, United States of America., Gilbert MR; Neuro-Oncology Branch, Center for Cancer Research, US National Cancer Institute, 9030 Old Georgetown Road, Bldg 82, Bethesda, MD 20814, United States of America., Armstrong TS; Neuro-Oncology Branch, Center for Cancer Research, US National Cancer Institute, 9030 Old Georgetown Road, Bldg 82, Bethesda, MD 20814, United States of America., Mendoza TR; Office of Patient-Centered Outcomes Research, US National Cancer Institute, 9030 Old Georgetown Road, Bldg 82, Bethesda, MD 20814, United States of America.

Publikováno v: EClinicalMedicine [EClinicalMedicine] 2022 Nov 12; Vol. 55, pp. 101718. Date of Electronic Publication: 2022 Nov 12 (Print Publication: 2023).

Oral glucosamine for 6 weeks at standard doses does not cause or worsen insulin resistance or endothelial dysfunction in lean or obese subjects.

Autor: Muniyappa R; Chief, Diabetes Unit, National Center for Complementary and Alternative Medicine, National Institutes of Health, 10 Center Dr., Bldg. 10, Rm. 6C-205, Bethesda, MD 20892, USA., Karne RJ, Hall G, Crandon SK, Bronstein JA, Ver MR, Hortin GL, Quon MJ

Publikováno v: Diabetes [Diabetes] 2006 Nov; Vol. 55 (11), pp. 3142-50.